Data:
{
"symbol": "RPRX",
"price": 63.11,
"marketCap": 27975022140,
"beta": 0.425,
"lastDividend": 0.925,
"range": "34.081-63.285",
"change": 0.79,
"changePercentage": 1.26765,
"volume": 3142662,
"averageVolume": 3414937,
"companyName": "Royalty Pharma plc",
"currency": "USD",
"cik": "0001802768",
"isin": "GB00BMVP7Y09",
"cusip": "G7709Q104",
"exchangeFullName": "NASDAQ",
"exchange": "NASDAQ",
"industry": "Medical - Pharmaceuticals",
"website": "https://www.royaltypharma.com",
"description": "Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.",
"ceo": "Pablo Legorreta",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "100",
"phone": "212 883 0200",
"address": "110 East 59th Street",
"city": "New York",
"state": "NY",
"zip": "10022",
"image": "https://images.financialmodelingprep.com/symbol/RPRX.png",
"ipoDate": "2020-06-16",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "RPRX",
"name": "Royalty Pharma plc",
"price": 63.88,
"changePercentage": 1.22009,
"change": 0.77,
"volume": 2761452,
"dayLow": 62.5,
"dayHigh": 63.94,
"yearHigh": 63.94,
"yearLow": 34.081,
"marketCap": 28316343120,
"priceAvg50": 58.7577,
"priceAvg200": 49.10997,
"exchange": "NASDAQ",
"open": 63.565,
"previousClose": 63.11,
"timestamp": 1788465600,
"chart_vwap_daily": [
{
"t": "2026-07-24",
"v": 58.9183,
"c": 58.83
},
{
"t": "2026-07-27",
"v": 58.9027,
"c": 58.73
},
{
"t": "2026-07-28",
"v": 59.7227,
"c": 59.97
},
{
"t": "2026-07-29",
"v": 59.7542,
"c": 59.18
},
{
"t": "2026-07-30",
"v": 59.1431,
"c": 59.02
},
{
"t": "2026-07-31",
"v": 58.5508,
"c": 58.43
},
{
"t": "2026-08-03",
"v": 57.2948,
"c": 57.17
},
{
"t": "2026-08-04",
"v": 57.4888,
"c": 57.48
},
{
"t": "2026-08-05",
"v": 57.8977,
"c": 57.75
},
{
"t": "2026-08-06",
"v": 57.2795,
"c": 57.26
},
{
"t": "2026-08-07",
"v": 56.8786,
"c": 56.77
},
{
"t": "2026-08-10",
"v": 57.7029,
"c": 57.97
},
{
"t": "2026-08-11",
"v": 58.153,
"c": 57.79
},
{
"t": "2026-08-12",
"v": 59.0463,
"c": 59.22
},
{
"t": "2026-08-13",
"v": 58.6261,
"c": 58.56
},
{
"t": "2026-08-14",
"v": 58.543,
"c": 58.6
},
{
"t": "2026-08-17",
"v": 59.2503,
"c": 59.45
},
{
"t": "2026-08-18",
"v": 59.911,
"c": 59.69
},
{
"t": "2026-08-19",
"v": 61.2917,
"c": 61.73
},
{
"t": "2026-08-20",
"v": 60.9326,
"c": 60.58
},
{
"t": "2026-08-21",
"v": 61.2262,
"c": 61.31
},
{
"t": "2026-08-24",
"v": 61.2415,
"c": 61.33
},
{
"t": "2026-08-25",
"v": 62.0103,
"c": 62.07
},
{
"t": "2026-08-26",
"v": 61.8936,
"c": 61.8
},
{
"t": "2026-08-27",
"v": 61.9103,
"c": 61.92
},
{
"t": "2026-08-28",
"v": 60.8925,
"c": 60.85
},
{
"t": "2026-08-31",
"v": 61.3565,
"c": 61.41
},
{
"t": "2026-09-01",
"v": 62.1395,
"c": 62.32
},
{
"t": "2026-09-02",
"v": 62.7293,
"c": 63.11
},
{
"t": "2026-09-03",
"v": 63.4767,
"c": 63.88
}
],
"vwap_summary": {
"days": 30,
"days_above": 14,
"days_below": 16,
"pct_days_above": 47,
"position": "above",
"gap_pct": 0.64,
"streak_days": 4
}
}
Data:
{
"volume": 2761452,
"avgVolume": 3414937,
"short_ratio": [
{
"symbol": "RPRX",
"file_date": "2026-09-03",
"date": "20260903",
"short_volume": 652377,
"short_exempt_volume": 1,
"total_volume": 1149158,
"short_volume_ratio": 0.5677,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 61.37,
"vah": 63.87,
"val": 59.1,
"profile": [
{
"price": 57.26,
"volume": 200303
},
{
"price": 57.38,
"volume": 538808
},
{
"price": 57.49,
"volume": 364501
},
{
"price": 57.6,
"volume": 946874
},
{
"price": 57.71,
"volume": 326853
},
{
"price": 57.82,
"volume": 317570
},
{
"price": 57.93,
"volume": 534747
},
{
"price": 58.04,
"volume": 355324
},
{
"price": 58.15,
"volume": 267211
},
{
"price": 58.26,
"volume": 628965
},
{
"price": 58.37,
"volume": 694615
},
{
"price": 58.49,
"volume": 775399
},
{
"price": 58.6,
"volume": 1177900
},
{
"price": 58.71,
"volume": 376353
},
{
"price": 58.82,
"volume": 530782
},
{
"price": 58.93,
"volume": 999227
},
{
"price": 59.04,
"volume": 1445413
},
{
"price": 59.15,
"volume": 943850
},
{
"price": 59.26,
"volume": 1072604
},
{
"price": 59.37,
"volume": 590689
},
{
"price": 59.48,
"volume": 31493
},
{
"price": 59.59,
"volume": 0
},
{
"price": 59.71,
"volume": 234570
},
{
"price": 59.82,
"volume": 340040
},
{
"price": 59.93,
"volume": 360581
},
{
"price": 60.04,
"volume": 501659
},
{
"price": 60.15,
"volume": 187321
},
{
"price": 60.26,
"volume": 132679
},
{
"price": 60.37,
"volume": 97909
},
{
"price": 60.48,
"volume": 201012
},
{
"price": 60.59,
"volume": 554636
},
{
"price": 60.7,
"volume": 623902
},
{
"price": 60.82,
"volume": 1130092
},
{
"price": 60.93,
"volume": 971379
},
{
"price": 61.04,
"volume": 1477222
},
{
"price": 61.15,
"volume": 1466642
},
{
"price": 61.26,
"volume": 1182373
},
{
"price": 61.37,
"volume": 1870904
},
{
"price": 61.48,
"volume": 953887
},
{
"price": 61.59,
"volume": 857849
},
{
"price": 61.7,
"volume": 995232
},
{
"price": 61.81,
"volume": 653591
},
{
"price": 61.92,
"volume": 1644523
},
{
"price": 62.04,
"volume": 1201478
},
{
"price": 62.15,
"volume": 880979
},
{
"price": 62.26,
"volume": 1157255
},
{
"price": 62.37,
"volume": 409675
},
{
"price": 62.48,
"volume": 562355
},
{
"price": 62.59,
"volume": 227756
},
{
"price": 62.7,
"volume": 179934
},
{
"price": 62.81,
"volume": 588059
},
{
"price": 62.92,
"volume": 382170
},
{
"price": 63.03,
"volume": 98185
},
{
"price": 63.15,
"volume": 585429
},
{
"price": 63.26,
"volume": 277580
},
{
"price": 63.37,
"volume": 230192
},
{
"price": 63.48,
"volume": 204595
},
{
"price": 63.59,
"volume": 241236
},
{
"price": 63.7,
"volume": 403200
},
{
"price": 63.81,
"volume": 303812
}
],
"sessions": 20
}
}
Data:
{
"symbol": "RPRX",
"marketCap": 28316343120,
"enterpriseValueTTM": 36466235120,
"evToSalesTTM": 14.379441592619552,
"evToOperatingCashFlowTTM": 12.251557848811524,
"evToFreeCashFlowTTM": 12.251557848811524,
"evToEBITDATTM": 21.252230706378892,
"netDebtToEBITDATTM": 4.749691994419184,
"currentRatioTTM": 1.286993127583496,
"incomeQualityTTM": 3.7199946508291215,
"grahamNumberTTM": 25.15511232552817,
"grahamNetNetTTM": -19.165579557097406,
"taxBurdenTTM": 0.6039895811880587,
"interestBurdenTTM": 0.7889616234350708,
"workingCapitalTTM": 181072000,
"investedCapitalTTM": 1104607000,
"returnOnAssetsTTM": 0.041135469223007065,
"operatingReturnOnAssetsTTM": 0.07977809744139175,
"returnOnTangibleAssetsTTM": 0.04314590056923345,
"returnOnEquityTTM": 0.12254451690111573,
"returnOnInvestedCapitalTTM": 0.08961132165645529,
"returnOnCapitalEmployedTTM": 0.08239163415510661,
"earningsYieldTTM": 0.028676934966307563,
"freeCashFlowYieldTTM": 0.10511445589517916,
"capexToOperatingCashFlowTTM": 0,
"capexToDepreciationTTM": 0,
"capexToRevenueTTM": 0,
"salesGeneralAndAdministrativeToRevenueTTM": 0.23812834237250977,
"researchAndDevelopementToRevenueTTM": 0.0943813835815328,
"stockBasedCompensationToRevenueTTM": 0.07831630782043203,
"intangiblesToTotalAssetsTTM": 0.04659611503531786,
"averageReceivablesTTM": 848404500,
"averagePayablesTTM": 30524500,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 128.01694244238362,
"daysOfPayablesOutstandingTTM": 48.18937068232691,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 128.01694244238362,
"cashConversionCycleTTM": 79.82757176005671,
"freeCashFlowToEquityTTM": 3930932000,
"freeCashFlowToFirmTTM": 3337531000,
"tangibleAssetValueTTM": 8862465000,
"netCurrentAssetValueTTM": -9222000000,
"grossProfitMarginTTM": 0.8937747584974436,
"ebitMarginTTM": 0.6746614153481194,
"ebitdaMarginTTM": 0.6766085777670172,
"operatingProfitMarginTTM": 0.6234306967119059,
"pretaxProfitMarginTTM": 0.5322819655220549,
"continuousOperationsProfitMarginTTM": 0.5322819655220549,
"netProfitMarginTTM": 0.3214927614296226,
"bottomLineProfitMarginTTM": 0.38162017477931764,
"receivablesTurnoverTTM": 2.8511851090669107,
"payablesTurnoverTTM": 7.574284428948996,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 0,
"assetTurnoverTTM": 0.12795146316851666,
"quickRatioTTM": 1.286993127583496,
"solvencyRatioTTM": 0.08174636236794898,
"cashRatioTTM": 1.286993127583496,
"priceToEarningsRatioTTM": 26.50622406639004,
"priceToEarningsGrowthRatioTTM": 7.7199377593360925,
"forwardPriceToEarningsGrowthRatioTTM": 3.463493809915711,
"priceToEarningsDilutedRatioTTM": 36.712643678160916,
"priceToEarningsDilutedGrowthRatioTTM": -1.888078817733988,
"priceToBookRatioTTM": 4.160950435835469,
"priceToSalesRatioTTM": 11.165759247444202,
"priceToFreeCashFlowRatioTTM": 9.513439340800153,
"priceToOperatingCashFlowRatioTTM": 9.551855887721542,
"debtToAssetsRatioTTM": 0.4521640766902119,
"debtToEquityRatioTTM": 1.311610468364151,
"debtToCapitalRatioTTM": 0.5674011630914327,
"longTermDebtToCapitalRatioTTM": 0.5567367781946905,
"financialLeverageRatioTTM": 2.900740098516861,
"workingCapitalTurnoverRatioTTM": 4.7348686194281,
"operatingCashFlowRatioTTM": 4.717585841807623,
"operatingCashFlowSalesRatioTTM": 1.1736827079516625,
"freeCashFlowOperatingCashFlowRatioTTM": 1,
"debtServiceCoverageRatioTTM": 2.3153936044173724,
"interestCoverageRatioTTM": 4.378656452693908,
"shortTermOperatingCashFlowCoverageRatioTTM": 7.832781578947368,
"operatingCashFlowCoverageRatioTTM": 0.33212373012305885,
"capitalExpenditureCoverageRatioTTM": 0,
"dividendPaidAndCapexCoverageRatioTTM": 7.458651684830139,
"dividendPayoutRatioTTM": 0.48946222579280146,
"dividendYieldTTM": 0.01448028,
"revenuePerShareTTM": 5.698052414933582,
"netIncomePerShareTTM": 1.831882605647727,
"interestDebtPerShareTTM": 20.947472723024106,
"cashPerShareTTM": 1.8806284040048173,
"bookValuePerShareTTM": 21.98784893857962,
"tangibleBookValuePerShareTTM": 19.91278782377366,
"shareholdersEquityPerShareTTM": 15.35226169719411,
"operatingCashFlowPerShareTTM": 6.687705588409757,
"capexPerShareTTM": 0,
"freeCashFlowPerShareTTM": 6.687705588409757,
"netIncomePerEBTTTM": 0.6039895811880587,
"ebtPerEbitTTM": 0.8537949259306814,
"priceToFairValueTTM": 4.160950435835469,
"debtToMarketCapTTM": 0.3164918563820539,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": 21.252230706378892,
"dividendPerShareTTM": 0.925,
"revenue_history": [
{
"date": "2025",
"revenue": 2378193000
}
],
"dcf": {
"symbol": "RPRX",
"date": "2026-09-04",
"dcf": 21.040963360232244,
"Stock Price": 63.88
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "RPRX",
"reportedCurrency": "USD",
"cik": "0001802768",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 09:04:11",
"fiscalYear": "2025",
"period": "FY",
"revenue": 2378193000,
"costOfRevenue": 0,
"grossProfit": 2378193000,
"researchAndDevelopmentExpenses": 452000000,
"generalAndAdministrativeExpenses": 573481000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 573481000,
"otherExpenses": -206806000,
"operatingExpenses": 818675000,
"costAndExpenses": 818675000,
"netInterestIncome": -274073000,
"interestIncome": 33591000,
"interestExpense": 307664000,
"depreciationAndAmortization": 3852000,
"ebitda": 1635708000,
"ebit": 1631856000,
"nonOperatingIncomeExcludingInterest": -72338000,
"operatingIncome": 1559518000,
"totalOtherIncomeExpensesNet": -235326000,
"incomeBeforeTax": 1324192000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": 1324192000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 770947000,
"netIncomeDeductions": -234575000,
"bottomLineNetIncome": 1005522000,
"eps": 2.33,
"epsDiluted": 1.8,
"weightedAverageShsOut": 431887000,
"weightedAverageShsOutDil": 559611000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "RPRX",
"reportedCurrency": "USD",
"cik": "0001802768",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 09:04:11",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 618696000,
"shortTermInvestments": 18800000,
"cashAndShortTermInvestments": 637496000,
"netReceivables": 883702000,
"accountsReceivables": 883702000,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": -902198000,
"totalCurrentAssets": 619000000,
"propertyPlantEquipmentNet": 0,
"goodwill": 924634000,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 924634000,
"longTermInvestments": 171312000,
"taxAssets": 0,
"otherNonCurrentAssets": 15967054000,
"totalNonCurrentAssets": 17063000000,
"otherAssets": 1939000000,
"totalAssets": 19620780000,
"totalPayables": 92229000,
"accountPayables": 19404000,
"otherPayables": 72825000,
"accruedExpenses": 0,
"shortTermDebt": 380000000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 163982000,
"totalCurrentLiabilities": 636211000,
"longTermDebt": 8570917000,
"capitalLeaseObligationsNonCurrent": 16100000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 682613000,
"totalNonCurrentLiabilities": 9269630000,
"otherLiabilities": 0,
"capitalLeaseObligations": 16100000,
"totalLiabilities": 9905841000,
"treasuryStock": -2612000,
"preferredStock": 0,
"commonStock": 106000,
"retainedEarnings": 2356318000,
"additionalPaidInCapital": 4123088000,
"accumulatedOtherComprehensiveIncomeLoss": 0,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 6476900000,
"totalEquity": 9714939000,
"minorityInterest": 3238039000,
"totalLiabilitiesAndTotalEquity": 19620780000,
"totalInvestments": 190112000,
"totalDebt": 8950917000,
"netDebt": 8332221000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "RPRX",
"reportedCurrency": "USD",
"cik": "0001802768",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 09:04:11",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 1324192000,
"depreciationAndAmortization": 3852000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 289894000,
"changeInWorkingCapital": -17151000,
"accountsReceivables": -2360000,
"inventory": 0,
"accountsPayables": -13928000,
"otherWorkingCapital": -863000,
"otherNonCashItems": 889036000,
"netCashProvidedByOperatingActivities": 2489823000,
"investmentsInPropertyPlantAndEquipment": 0,
"acquisitionsNet": -74416000,
"purchasesOfInvestments": -1931156000,
"salesMaturitiesOfInvestments": 566502000,
"otherInvestingActivities": -175110000,
"netCashProvidedByInvestingActivities": -1614180000,
"netDebtIssuance": 954475000,
"longTermNetDebtIssuance": 954475000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -1227383000,
"netCommonStockIssuance": -1227383000,
"commonStockIssuance": 0,
"commonStockRepurchased": -1227383000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": -378253000,
"commonDividendsPaid": -378253000,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -534812000,
"netCashProvidedByFinancingActivities": -1185973000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": -310330000,
"cashAtEndOfPeriod": 618696000,
"cashAtBeginningOfPeriod": 929026000,
"operatingCashFlow": 2489823000,
"capitalExpenditure": 0,
"freeCashFlow": 2489823000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 63.88,
"rsi": 69.4064842160291,
"sma20": 60.517999999999915,
"sma50": 58.75779999999993,
"sma200": 49.10999999999997,
"adx": 33.480168919881834,
"atr": 1.31,
"atr_pct": 2.05,
"atr_expansion_pct": -15.3,
"di_plus": 35.6,
"di_minus": 6.0,
"high_52w": 63.88,
"low_52w": 34.9,
"structure": {
"ema8": 62.262712413040155,
"ema21": 60.85440403191276,
"ema50": 58.778800627406184,
"ema200": 50.61014103148747,
"ema10": 61.995942540238545,
"ema20": 60.94183841265829,
"ema10_slope_pct": 1.77,
"ema20_slope_pct": 1.65,
"trend_dir": "up",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": true,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": true
},
"dist_21ema_pct": 5.0,
"_no_bars": false,
"macd": {
"macd": 1.303,
"signal": 1.094,
"histogram": 0.209
},
"bollinger": {
"mid": 60.52,
"upper": 64.26,
"lower": 56.78,
"width_pct": 12.36
},
"crossover": {
"fresh_cross": false,
"pre_compressed": true,
"held_above_21": true,
"candles_since": 18,
"intraday_support": false
},
"momentum": {
"roc10": 5.4,
"ret_3d": 4.02,
"ret_5d": 3.17,
"roc10_accel": -0.29,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 1.03,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": true,
"surge_day": false,
"pullback_declining_vol": true,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 0.5,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": true,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 215516674.07,
"avg_vol": 3414937
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.5,
"iv_rank": 34.0
}
}
}
}
Data:
{
"prior_day": {
"high": 63.94,
"low": 62.5,
"close": 63.88,
"date": "2026-09-03"
},
"woodie_pivots": {
"PP": 63.55,
"R1": 64.6,
"S1": 63.16,
"R2": 64.99,
"S2": 62.11
},
"swing": {
"high_20d": 63.94,
"low_20d": 56.53,
"high_60d": 63.94,
"low_60d": 51.15
},
"orb": {
"high": 63.56,
"low": 63.12,
"date": "2026-09-03"
},
"vwap": 63.4,
"volume_profile": {
"poc": 61.37,
"vah": 63.87,
"val": 59.1,
"sessions": 20
},
"premarket": {
"date": "2026-09-04",
"high": 64,
"low": 63.7,
"last": 63.75,
"volume": 1420,
"gap_pct": -0.2,
"path": "04:35 63.77 -> 06:20 63.73 -> 07:05 63.79 -> 07:20 63.70 -> 08:30 63.70 -> 09:05 64.00 -> 09:10 63.75",
"bars": 7,
"last_bar_et": "09:10"
},
"recent_daily": [
{
"d": "2026-07-31",
"o": 58.63,
"h": 59.1173,
"l": 58.26,
"c": 58.43,
"v": 2156928.806562
},
{
"d": "2026-08-03",
"o": 58.26,
"h": 58.29,
"l": 56.97,
"c": 57.17,
"v": 2747780.32336
},
{
"d": "2026-08-04",
"o": 57.17,
"h": 58.035,
"l": 56.36,
"c": 57.48,
"v": 3684203.910713
},
{
"d": "2026-08-05",
"o": 59.53,
"h": 59.6295,
"l": 57.41,
"c": 57.75,
"v": 3536502.443486
},
{
"d": "2026-08-06",
"o": 58.94,
"h": 59.19,
"l": 56.83,
"c": 57.26,
"v": 2441510.2366
},
{
"d": "2026-08-07",
"o": 57.44,
"h": 57.66,
"l": 56.6,
"c": 56.77,
"v": 4159405.861011
},
{
"d": "2026-08-10",
"o": 57.43,
"h": 58.03,
"l": 56.5301,
"c": 57.97,
"v": 4264216.539644
},
{
"d": "2026-08-11",
"o": 58.04,
"h": 58.63,
"l": 57.76,
"c": 57.79,
"v": 2394337.741392
},
{
"d": "2026-08-12",
"o": 57.75,
"h": 59.33,
"l": 57.65,
"c": 59.22,
"v": 3924340.325972
},
{
"d": "2026-08-13",
"o": 59.5,
"h": 59.58,
"l": 57.945,
"c": 58.56,
"v": 2516784.513205
},
{
"d": "2026-08-14",
"o": 57.89,
"h": 58.78,
"l": 57.72,
"c": 58.6,
"v": 1596476.834112
},
{
"d": "2026-08-17",
"o": 58.36,
"h": 59.49,
"l": 58.18,
"c": 59.45,
"v": 2359984.022373
},
{
"d": "2026-08-18",
"o": 59.74,
"h": 60.42,
"l": 59.655,
"c": 59.69,
"v": 2075199.34537
},
{
"d": "2026-08-19",
"o": 60.12,
"h": 61.8,
"l": 59.75,
"c": 61.73,
"v": 3256561.748899
},
{
"d": "2026-08-20",
"o": 61.33,
"h": 62.13,
"l": 60.37,
"c": 60.58,
"v": 3143107.336593
},
{
"d": "2026-08-21",
"o": 60.53,
"h": 61.6,
"l": 60.37,
"c": 61.31,
"v": 2325104.352108
},
{
"d": "2026-08-24",
"o": 61.19,
"h": 61.54,
"l": 60.8043,
"c": 61.33,
"v": 2357873.708574
},
{
"d": "2026-08-25",
"o": 61.33,
"h": 62.455,
"l": 60.87,
"c": 62.07,
"v": 1705153.403686
},
{
"d": "2026-08-26",
"o": 62.04,
"h": 62.28,
"l": 61.49,
"c": 61.8,
"v": 1478067.653277
},
{
"d": "2026-08-27",
"o": 61.42,
"h": 62.35,
"l": 61.01,
"c": 61.92,
"v": 2094005.021417
},
{
"d": "2026-08-28",
"o": 61.92,
"h": 62.01,
"l": 60.6553,
"c": 60.85,
"v": 1701654.010599
},
{
"d": "2026-08-31",
"o": 60.805,
"h": 61.68,
"l": 60.39,
"c": 61.41,
"v": 3895209.859212
},
{
"d": "2026-09-01",
"o": 61.815,
"h": 62.58,
"l": 61.61,
"c": 62.32,
"v": 2629306.27767
},
{
"d": "2026-09-02",
"o": 62.66,
"h": 63.285,
"l": 62.03,
"c": 63.11,
"v": 3143774.675542
},
{
"d": "2026-09-03",
"o": 63.565,
"h": 63.94,
"l": 62.5,
"c": 63.88,
"v": 2761485.414621
}
]
}
Data:
{
"estimates": [
{
"symbol": "RPRX",
"date": "2030-12-31",
"revenueLow": 4787528470,
"revenueHigh": 5052447580,
"revenueAvg": 4910000000,
"ebitdaLow": 5422998572,
"ebitdaHigh": 5798625060,
"ebitdaAvg": 5596647991,
"ebitLow": 5421736349,
"ebitHigh": 5797362837,
"ebitAvg": 5595385768,
"netIncomeLow": 4093476126,
"netIncomeHigh": 4390221052,
"netIncomeAvg": 4230659167,
"sgaExpenseLow": 606315782,
"sgaExpenseHigh": 639866421,
"sgaExpenseAvg": 621826170,
"epsAvg": 7.56,
"epsHigh": 7.84513,
"epsLow": 7.31486,
"numAnalystsRevenue": 2,
"numAnalystsEps": 1
},
{
"symbol": "RPRX",
"date": "2029-12-31",
"revenueLow": 4426757486,
"revenueHigh": 4671713241,
"revenueAvg": 4540000000,
"ebitdaLow": 5005220957,
"ebitdaHigh": 5350536363,
"ebitdaAvg": 5164858849,
"ebitLow": 5003643178,
"ebitHigh": 5348958584,
"ebitAvg": 5163281070,
"netIncomeLow": 3763182521,
"netIncomeHigh": 4035981692,
"netIncomeAvg": 3889296456,
"sgaExpenseLow": 560625998,
"sgaExpenseHigh": 591648381,
"sgaExpenseAvg": 574967579,
"epsAvg": 6.95,
"epsHigh": 7.21212,
"epsLow": 6.72464,
"numAnalystsRevenue": 2,
"numAnalystsEps": 1
},
{
"symbol": "RPRX",
"date": "2028-12-31",
"revenueLow": 3845005060,
"revenueHigh": 4355451934,
"revenueAvg": 4135508157,
"ebitdaLow": 3410837388,
"ebitdaHigh": 6245387531,
"ebitdaAvg": 4740886515,
"ebitLow": 3408865164,
"ebitHigh": 6243415307,
"ebitAvg": 4738914291,
"netIncomeLow": 2503307890,
"netIncomeHigh": 4742602503,
"netIncomeAvg": 3554046700,
"sgaExpenseLow": 486950055,
"sgaExpenseHigh": 551595518,
"sgaExpenseAvg": 523740773,
"epsAvg": 6.47406,
"epsHigh": 8.47482,
"epsLow": 4.4733,
"numAnalystsRevenue": 4,
"numAnalystsEps": 2
},
{
"symbol": "RPRX",
"date": "2027-12-31",
"revenueLow": 3758746842,
"revenueHigh": 3860334595,
"revenueAvg": 3809540719,
"ebitdaLow": 3917601309,
"ebitdaHigh": 4533768439,
"ebitdaAvg": 4313915229,
"ebitLow": 3915136029,
"ebitHigh": 4531303159,
"ebitAvg": 4311449949,
"netIncomeLow": 2903261873,
"netIncomeHigh": 3390033906,
"netIncomeAvg": 3216349870,
"sgaExpenseLow": 476025897,
"sgaExpenseHigh": 488891461,
"sgaExpenseAvg": 482458679,
"epsAvg": 5.73683,
"epsHigh": 6.05784,
"epsLow": 5.188,
"numAnalystsRevenue": 4,
"numAnalystsEps": 4
}
],
"price_target": {
"symbol": "RPRX",
"targetHigh": 66,
"targetLow": 57,
"targetConsensus": 62.67,
"targetMedian": 65
},
"ratings": {
"symbol": "RPRX",
"rating": "B",
"overallScore": 3,
"discountedCashFlowScore": 4,
"returnOnEquityScore": 4,
"returnOnAssetsScore": 4,
"debtToEquityScore": 1,
"priceToEarningsScore": 2,
"priceToBookScore": 2
},
"grades": [
{
"symbol": "RPRX",
"date": "2026-08-07",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "RPRX",
"date": "2026-07-13",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "RPRX",
"date": "2026-05-07",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "RPRX",
"date": "2026-05-07",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "RPRX",
"date": "2026-04-21",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "RPRX",
"date": "2026-04-10",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "RPRX",
"date": "2026-01-30",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "RPRX",
"date": "2026-01-27",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "RPRX",
"date": "2025-12-11",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "RPRX",
"date": "2025-10-10",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Royalty Pharma (RPRX) Bets $100M On A Blood Disorder Breakthrough",
"url": "https://finance.yahoo.com/healthcare/articles/royalty-pharma-rprx-bets-100m-175445428.html",
"source": "Yahoo! Finance",
"date": "2026-09-01T17:54:45Z",
"summary": "On August 12, Royalty Pharma (NASDAQ:RPRX) agreed to pay Zealand Pharma $100 million for the rights to future royalties on rusfertide, an experimental treatment for a rare blood disorder called polycythemia vera. It is Royalty Pharma's second collaboration with Zealand, and it ar",
"image": "https://s.yimg.com/lo/mysterio/api/83e79646cb2ab264f779d5fc4a53ade8c03a5060a7ae0a779bcfdd9c7b5a41e1/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F5786f8c71c314f7987a27ae78a612d6d.jpg"
},
{
"title": "Royalty Pharma: Strong Execution, Higher Guidance, And Room For A Re-Rating",
"url": "https://seekingalpha.com/article/4940417-royalty-pharma-strong-execution-higher-guidance-and-room-for-a-re-rating",
"source": "Seeking Alpha",
"date": "2026-08-26 12:02:46",
"summary": "Royalty Pharma continues to deliver solid portfolio execution, supported by robust management and increased scalability for higher-value transactions. The company is capitalizing on inflows into the biopharma sector, with a strategic shift toward development-stage assets that yie",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-strong-execution-higher-guidance-and-room-for-20260826.jpg"
},
{
"title": "Royalty Pharma: The Quiet Compounder The Market Is Still Mispricing",
"url": "https://seekingalpha.com/article/4940292-royalty-pharma-the-quiet-compounder-the-market-is-still-mispricing",
"source": "Seeking Alpha",
"date": "2026-08-26 06:59:59",
"summary": "Royalty Pharma demonstrates high-quality, cash-generative compounding with durable royalty growth and disciplined capital deployment, supporting a buy rating. RPRX's 2Q26 results highlight 14% Royalty Receipts growth, elite 95% margins, and $728 million operating cash flow, reinf",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-the-quiet-compounder-the-market-is-still-20260826.jpg"
},
{
"title": "MRK, RPRX Stocks Hit 52-Week Highs - What Drove Today's Gains?",
"url": "https://finance.yahoo.com/markets/stocks/articles/mrk-rprx-stocks-hit-52-182459492.html",
"source": "Yahoo! Finance",
"date": "2026-08-25T18:24:59Z",
"summary": "* Wolfe Research raised MRK's target to $180 from $155 and maintained an 'Outperform' rating, according to The Fly.\n\n* The brokerage said Keytruda QLEX with Intismeran will soften the impact of Keytruda's exclusivity loss.\n\n* Royalty Pharma stands to gain 30% of future royalties ",
"image": "https://s.yimg.com/lo/mysterio/api/cee111ffd75019412529807ba5891c8aaa187c44e2603d2a218a7409135453a5/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fstocktwits_383%2Fa4679fcf550d2806b58f6caa3fe226c0"
},
{
"title": "Royalty Pharma EVP & CFO Terrance Coyne sells $645k in shares By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/royalty-pharma-evp--cfo-terrance-coyne-sells-645k-in-shares-93CH-4864015",
"source": "Investing.com",
"date": "2026-08-17T21:30:59Z",
"summary": "Terrance P. Coyne, Executive Vice President and Chief Financial Officer of Royalty Pharma plc (NASDAQ:RPRX), sold a total of 11,002 Class A Ordinary Shares on August 13, 2026, for a total value of $645,551. The sales were executed at prices ranging from $57.99 to $59.52 per share",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4416N_1200_L.jpg"
},
{
"title": "Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?",
"url": "https://finance.yahoo.com/healthcare/articles/royalty-pharma-plc-rprx-vs-222710878.html",
"source": "Yahoo! Finance",
"date": "2026-08-13T22:27:10Z",
"summary": "In the life sciences sector, capital allocation often tells a clearer story than pure drug discovery. While pharmaceutical giants spend billions to develop and commercialize late-stage therapies, specialized royalty acquirers deploy targeted capital to harvest the long-term cash ",
"image": "https://s.yimg.com/lo/mysterio/api/2B8650F474D8CE41DA747AECD2D3C8E1DF2ECEF1611781F0C3B962ADF5AF2A58/subgraphmysterio/resizefill_w1200_h673;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F4b9ae3e820991409356264f5ee1180f1.jpg"
},
{
"title": "Royalty Pharma (RPRX) Crossed Above the 20-Day Moving Average: What That Means for Investors",
"url": "https://www.zacks.com/stock/news/2974194/royalty-pharma-rprx-crossed-above-the-20-day-moving-average-what-that-means-for-investors?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|20_day_moving_average_(yseop)-2974194",
"source": "Zacks Investment Research",
"date": "2026-08-13 10:36:07",
"summary": "Royalty Pharma (RPRX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, RPRX crossed above the 20-day moving average, suggesting a short-term bullish trend.",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-rprx-crossed-above-the-20day-moving-average-20260813.jpg"
},
{
"title": "Zealand Pharma sells rusfertide royalty rights for $100 million By Investing.com",
"url": "https://www.investing.com/news/company-news/zealand-pharma-sells-rusfertide-royalty-rights-for-100-million-93CH-4855991",
"source": "Investing.com",
"date": "2026-08-12T20:12:32Z",
"summary": "COPENHAGEN - Zealand Pharma A/S (NASDAQ:ZEAL) announced today that it has sold its economic interests related to rusfertide to Royalty Pharma plc (NASDAQ:RPRX) for $100 million, according to a press release statement.\n\nUnder the agreement, Zealand Pharma will receive an upfront p",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png"
},
{
"title": "Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript",
"url": "https://finance.yahoo.com/healthcare/articles/royalty-pharma-rprx-q2-2026-135928969.html",
"source": "Yahoo! Finance",
"date": "2026-08-12T13:59:28Z",
"summary": "Image source: The Motley Fool.\n\nDATE\n\nWednesday, Aug. 5, 2026 at 8 a.m. ET\n\nCALL PARTICIPANTS\n\n* Chief Executive Officer and Chairman of the Board - Pablo Legorreta\n\n* Executive Vice President, Head of Research and Investments - Marshall Urist\n\n* Chairman, Partnering and Investme",
"image": "https://s.yimg.com/lo/mysterio/api/E291E5744742B27639572F2CD0432FD00A265DC302A2C312504B80A58B971163/subgraphmysterio/resizefill_w1200_h1281;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fmotleyfool.com%2Fe48e86dda35543079ee2080fd9208b73.png"
},
{
"title": "Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million",
"url": "https://www.globenewswire.com/news-release/2026/08/12/3344086/0/en/royalty-pharma-and-zealand-pharma-enter-into-rusfertide-funding-agreement-for-100-million.html",
"source": "GlobeNewsWire",
"date": "2026-08-12 16:10:00",
"summary": "NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced an agreement for $100 million in funding to Zealand Pharma in exchange for Zealand Pharma's economics related to rusfertide (PTG-300), a potential first-in-class therapy for polycythemia",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-and-zealand-pharma-enter-into-rusfertide-funding-20260812.jpg"
},
{
"title": "Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide",
"url": "https://www.globenewswire.com/news-release/2026/08/12/3344048/0/en/zealand-pharma-enters-into-a-usd-100-million-royalty-purchase-and-sale-agreement-with-royalty-pharma-for-the-economics-related-to-rusfertide.html",
"source": "GlobeNewsWire",
"date": "2026-08-12 16:05:00",
"summary": "Company announcement \u2013 No. 38 / 2026 Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma will receive USD 100 million for the sale of its economic interests related to rusferti",
"image": "https://images.financialmodelingprep.com/news/zealand-pharma-enters-into-a-usd-100-million-royalty-20260812.jpg"
},
{
"title": "Royalty Pharma Q2 Earnings Call Highlights",
"url": "https://finance.yahoo.com/healthcare/articles/royalty-pharma-q2-earnings-call-190402880.html",
"source": "Yahoo! Finance",
"date": "2026-08-05T19:04:02Z",
"summary": "* How Royalty Pharma Prints Cash Without Biotech's Biggest Risks\n\nRoyalty Pharma (NASDAQ:RPRX) raised its 2026 outlook for the second consecutive quarter after reporting higher second-quarter royalty receipts, continued capital deployment and progress across its development-stage",
"image": "https://s.yimg.com/lo/mysterio/api/84A16D38BC2D6B0BE79B5CA5ADD39E6A338502FC9E4430D21FDC89AED2AD673B/subgraphmysterio/resizefill_w1200_h675;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fmarketbeat_955%2Fbc3f0409de0b4c5a1db6963ae30126ff"
},
{
"title": "Royalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance",
"url": "https://finance.yahoo.com/healthcare/articles/royalty-pharma-plc-rprx-q2-190129969.html",
"source": "Yahoo! Finance",
"date": "2026-08-05T19:01:29Z",
"summary": "This article first appeared on GuruFocus.\n\n* Portfolio Receipts: Grew 6% in Q2 2026 to $773 million, ahead of expectations.\n\n* Royalty Receipts: Grew 14% in Q2 2026, driven by strong performances from Tremfya, Voranigo, Emdeltra, and Evrysdi.\n\n* Total Receipts: Grew 14% in Q2 202",
"image": "https://s.yimg.com/cv/apiv2/cv/apiv2/social/images/yahoo-finance-default-logo.png"
},
{
"title": "Royalty Pharma plc (RPRX) Q2 2026 Earnings Call Transcript",
"url": "https://seekingalpha.com/article/4930763-royalty-pharma-plc-rprx-q2-2026-earnings-call-transcript",
"source": "Seeking Alpha",
"date": "2026-08-05 12:30:11",
"summary": "Royalty Pharma plc (RPRX) Q2 2026 Earnings Call Transcript",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-plc-rprx-q2-2026-earnings-call-transcript-20260805.jpg"
},
{
"title": "Royalty Pharma (RPRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates",
"url": "https://www.zacks.com/stock/news/2968515/royalty-pharma-rprx-q2-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2968515",
"source": "Zacks Investment Research",
"date": "2026-08-05 10:31:21",
"summary": "Although the revenue and EPS for Royalty Pharma (RPRX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-rprx-q2-earnings-taking-a-look-at-20260805.jpg"
},
{
"title": "Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates",
"url": "https://www.zacks.com/stock/news/2968401/royalty-pharma-rprx-tops-q2-earnings-and-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2968401",
"source": "Zacks Investment Research",
"date": "2026-08-05 10:01:12",
"summary": "Royalty Pharma (RPRX) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.14 per share a year ago.",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-rprx-tops-q2-earnings-and-revenue-estimates-20260805.jpg"
},
{
"title": "Royalty Pharma reports second quarter 2026 results",
"url": "https://www.globenewswire.com/news-release/2026/08/05/3339177/0/en/royalty-pharma-reports-second-quarter-2026-results.html",
"source": "GlobeNewsWire",
"date": "2026-08-05 07:00:00",
"summary": "Portfolio Receipts growth of 6% to $773 million; Royalty Receipts growth of 14% Net cash provided by operating activities of $728 million Raised full year 2026 guidance: Portfolio Receipts expected to be $3,400 million to $3,500 million NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) --",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-reports-second-quarter-2026-results-20260805.jpg"
},
{
"title": "Gear Up for Royalty Pharma (RPRX) Q2 Earnings: Wall Street Estimates for Key Metrics",
"url": "https://www.zacks.com/stock/news/2967368/gear-up-for-royalty-pharma-rprx-q2-earnings-wall-street-estimates-for-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-2967368",
"source": "Zacks Investment Research",
"date": "2026-08-04 10:15:29",
"summary": "Beyond analysts' top-and-bottom-line estimates for Royalty Pharma (RPRX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.",
"image": "https://images.financialmodelingprep.com/news/gear-up-for-royalty-pharma-rprx-q2-earnings-wall-20260804.jpg"
},
{
"title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
"url": "https://www.zacks.com/stock/news/2966369/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|zacks_education_earnings_esp-2966369",
"source": "Zacks Investment Research",
"date": "2026-08-03 09:56:08",
"summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
"image": "https://images.financialmodelingprep.com/news/these-2-medical-stocks-could-beat-earnings-why-they-20260803.jpg"
},
{
"title": "Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives",
"url": "https://www.globenewswire.com/news-release/2026/08/03/3337481/0/en/Royalty-Pharma-appoints-Greg-Raskin-as-Senior-Vice-President-Head-of-Academic-Initiatives.html",
"source": "GlobeNewsWire",
"date": "2026-08-03 08:15:00",
"summary": "NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Greg Raskin, M.D. as Senior Vice President, Head of Academic Initiatives, effective August 2026. Greg will lead Royalty Pharma's outreach efforts with academic and non",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-appoints-greg-raskin-as-senior-vice-president-20260803.jpg"
},
{
"title": "Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
"url": "https://www.zacks.com/stock/news/2963364/royalty-pharma-rprx-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2963364",
"source": "Zacks Investment Research",
"date": "2026-07-29 11:02:11",
"summary": "Royalty Pharma (RPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"image": "https://images.financialmodelingprep.com/news/royalty-pharma-rprx-earnings-expected-to-grow-what-to-20260729.jpg"
},
{
"title": "Bank of New York Mellon Corp Reduces Stock Position in Royalty Pharma PLC $RPRX",
"url": "https://www.defenseworld.net/2026/07/23/bank-of-new-york-mellon-corp-reduces-stock-position-in-royalty-pharma-plc-rprx.html",
"source": "Defense World",
"date": "2026-07-23 04:07:27",
"summary": "Bank of New York Mellon Corp decreased its position in Royalty Pharma PLC (NASDAQ: RPRX) by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,302,043 shares of the biopharmaceutical company's stock",
"image": "https://images.financialmodelingprep.com/news/bank-of-new-york-mellon-corp-reduces-stock-position-20260723.png"
},
{
"title": "Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation",
"url": "https://www.globenewswire.com/news-release/2026/04/21/3278310/0/en/Royalty-Pharma-Launches-Global-Translational-Prize-to-Recognize-Breakthrough-Scientific-Innovation.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-21T17:00:00Z",
"summary": "Royalty Pharma announced the launch of the Royalty Pharma Translational Prize, a $1 million annual award recognizing exceptional achievements in translational medicine that bridge fundamental discovery and drug development. The prize will be administered independently and present",
"image": "https://ml.globenewswire.com/Resource/Download/d605b3b0-7ba0-46e1-a2d4-439ca98694f8"
},
{
"title": "Royalty Pharma Declares Second Quarter 2026 Dividend",
"url": "https://www.benzinga.com/pressreleases/26/04/g51880517/royalty-pharma-declares-second-quarter-2026-dividend?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-04-17T12:30:00Z",
"summary": "Royalty Pharma plc (NASDAQ: RPRX) announced a dividend of $0.235 per Class A ordinary share for Q2 2026, payable on June 10, 2026, to shareholders of record as of May 15, 2026. The company continues to generate returns from its portfolio of royalties on over 35 commercial pharmac",
"image": "https://cdn.benzinga.com/files/imagecache/bz2_opengraph_meta_image_400x300/sites/all/themes/bz2/images/bz-icon.png"
},
{
"title": "Zymeworks Appoints Kristin Stafford as Chief Financial Officer",
"url": "https://www.globenewswire.com/news-release/2026/04/01/3266402/0/en/Zymeworks-Appoints-Kristin-Stafford-as-Chief-Financial-Officer.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-01T10:00:00Z",
"summary": "Zymeworks Inc. announced the appointment of Kristin Stafford as Chief Financial Officer effective April 1, 2026. Stafford brings extensive experience from Royalty Pharma in strategic planning, capital allocation, and executing complex transactions. The appointment comes as Zymewo",
"image": "https://ml.globenewswire.com/Resource/Download/de376a45-7a16-49db-8ad4-65ff45472c90"
}
]
Data:
[
{
"symbol": "RPRX",
"date": "2026-11-04",
"epsActual": null,
"epsEstimated": 1.16,
"revenueActual": null,
"revenueEstimated": 877371300,
"lastUpdated": "2026-09-04"
},
{
"symbol": "RPRX",
"date": "2026-08-05",
"epsActual": 1.32,
"epsEstimated": 1.27,
"revenueActual": 773000000,
"revenueEstimated": 758926900,
"lastUpdated": "2026-09-04"
},
{
"symbol": "RPRX",
"date": "2026-05-06",
"epsActual": 1.3,
"epsEstimated": 1.21,
"revenueActual": 925000000,
"revenueEstimated": 881693000,
"lastUpdated": "2026-08-06"
},
{
"symbol": "RPRX",
"date": "2026-02-11",
"epsActual": 1.46,
"epsEstimated": 1.29,
"revenueActual": 874000000,
"revenueEstimated": 806959000,
"lastUpdated": "2026-05-11"
},
{
"symbol": "RPRX",
"date": "2025-11-05",
"epsActual": 1.17,
"epsEstimated": 0.994,
"revenueActual": 609291000,
"revenueEstimated": 717379933,
"lastUpdated": "2026-02-05"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "RPRX",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "RPRX",
"periods": [
{
"file_period": "202604b",
"settlement_date": "20260422",
"quantity_fails": 3,
"price": 49.48
},
{
"file_period": "202606a",
"settlement_date": "20260611",
"quantity_fails": 20,
"price": 54.52
},
{
"file_period": "202606b",
"settlement_date": "20260629",
"quantity_fails": 5715736,
"price": 56.23
},
{
"file_period": "202607a",
"settlement_date": "20260702",
"quantity_fails": 3,
"price": 55.78
},
{
"file_period": "202607b",
"settlement_date": "20260728",
"quantity_fails": 1565,
"price": 58.73
},
{
"file_period": "202608a",
"settlement_date": "20260803",
"quantity_fails": 254,
"price": 58.43
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "RPRX",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-18",
"reportingCik": "0001814238",
"companyCik": "0001802768",
"transactionType": "S-Sale",
"securitiesOwned": 370401,
"reportingName": "Hite Christopher",
"typeOfOwner": "officer: EVP & Chairman, Partnering",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 100000,
"price": 59.9725,
"securityName": "Class A Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1802768/000181423826000015/0001814238-26-000015-index.htm"
},
{
"symbol": "RPRX",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-19",
"reportingCik": "0001814238",
"companyCik": "0001802768",
"transactionType": "G-Gift",
"securitiesOwned": 23200,
"reportingName": "Hite Christopher",
"typeOfOwner": "officer: EVP & Chairman, Partnering",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16800,
"price": 0,
"securityName": "Class A Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1802768/000181423826000015/0001814238-26-000015-index.htm"
},
{
"symbol": "RPRX",
"filingDate": "2026-08-17",
"transactionDate": "2026-08-13",
"reportingCik": "0001814876",
"companyCik": "0001802768",
"transactionType": "S-Sale",
"securitiesOwned": 1772,
"reportingName": "Coyne Terrance P.",
"typeOfOwner": "officer: EVP & CFO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 9230,
"price": 58.5864,
"securityName": "Class A Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1802768/000181487626000027/0001814876-26-000027-index.htm"
},
{
"symbol": "RPRX",
"filingDate": "2026-08-17",
"transactionDate": "2026-08-13",
"reportingCik": "0001814876",
"companyCik": "0001802768",
"transactionType": "S-Sale",
"securitiesOwned": 0,
"reportingName": "Coyne Terrance P.",
"typeOfOwner": "officer: EVP & CFO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 1772,
"price": 59.1415,
"securityName": "Class A Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1802768/000181487626000027/0001814876-26-000027-index.htm"
},
{
"symbol": "RPRX",
"filingDate": "2026-08-07",
"transactionDate": "2026-08-05",
"reportingCik": "0001507678",
"companyCik": "0001802768",
"transactionType": "A-Award",
"securitiesOwned": 1307820,
"reportingName": "Legorreta Pablo G.",
"typeOfOwner": "director, officer: CEO, Chairman of the Board",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 65216,
"price": 0,
"securityName": "Class A Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1802768/000150767826000006/0001507678-26-000006-index.htm"
},
{
"symbol": "RPRX",
"filingDate": "2026-08-07",
"transactionDate": "2026-08-07",
"reportingCik": "0001507678",
"companyCik": "0001802768",
"transactionType": "G-Gift",
"securitiesOwned": 662701,
"reportingName": "Legorreta Pablo G.",
"typeOfOwner": "director, officer: CEO, Chairman of the Board",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 30000,
"price": 0,
"securityName": "LP interests in RPI US Partners 2019, LP",
"url": "https://www.sec.gov/Archives/edgar/data/1802768/000150767826000006/0001507678-26-000006-index.htm"
},
{
"symbol": "RPRX",
"filingDate": "2026-08-07",
"transactionDate": "2026-08-07",
"reportingCik": "0001814876",
"companyCik": "0001802768",
"transactionType": "G-Gift",
"securitiesOwned": 1788777,
"reportingName": "Coyne Terrance P.",
"typeOfOwner": "officer: EVP & CFO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 18500,
"price": 0,
"securityName": "Class E Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1802768/000181487626000025/0001814876-26-000025-index.htm"
},
{
"symbol": "RPRX",
"filingDate": "2026-08-07",
"transactionDate": "2026-08-05",
"reportingCik": "0001814876",
"companyCik": "0001802768",
"transactionType": "A-Award",
"securitiesOwned": 11002,
"reportingName": "Coyne Terrance P.",
"typeOfOwner": "officer: EVP & CFO",
"acquisitionOrDisposition": "A",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 11002,
"price": 0,
"securityName": "Class A Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1802768/000181487626000025/0001814876-26-000025-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "RPRX",
"executed_at": "2026-09-03T20:00:07.132000Z",
"size": 6943.0,
"price": 63.88,
"premium": 443518.84,
"volume": 6943.0,
"trade_code": " "
},
{
"ticker": "RPRX",
"executed_at": "2026-09-03T20:00:03.061000Z",
"size": 4465.0,
"price": 63.88,
"premium": 285224.2,
"volume": 4465.0,
"trade_code": " "
},
{
"ticker": "RPRX",
"executed_at": "2026-09-03T20:00:28.027000Z",
"size": 3581.0,
"price": 63.88,
"premium": 228754.28,
"volume": 3581.0,
"trade_code": " "
},
{
"ticker": "RPRX",
"executed_at": "2026-09-03T20:00:23.514000Z",
"size": 3238.0,
"price": 63.88,
"premium": 206843.44,
"volume": 3238.0,
"trade_code": " "
},
{
"ticker": "RPRX",
"executed_at": "2026-09-03T20:00:23.769000Z",
"size": 3203.0,
"price": 63.88,
"premium": 204607.64,
"volume": 3203.0,
"trade_code": " "
},
{
"ticker": "RPRX",
"executed_at": "2026-09-03T20:00:23.551000Z",
"size": 1683.0,
"price": 63.88,
"premium": 107510.04000000001,
"volume": 1683.0,
"trade_code": " "
},
{
"ticker": "RPRX",
"executed_at": "2026-09-03T20:00:01.307000Z",
"size": 1669.0,
"price": 63.88,
"premium": 106615.72,
"volume": 1669.0,
"trade_code": " "
},
{
"ticker": "RPRX",
"executed_at": "2026-09-03T20:00:23.558000Z",
"size": 1595.0,
"price": 63.88,
"premium": 101888.6,
"volume": 1595.0,
"trade_code": " "
}
],
"ats": {
"symbol": "RPRX",
"date": "20260903",
"ats_volume": 0,
"total_volume": 1149158,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260903",
"ats_ratio": 0.0
},
{
"date": "20260902",
"ats_ratio": 0.0
},
{
"date": "20260901",
"ats_ratio": 0.0
},
{
"date": "20260831",
"ats_ratio": 0.0
},
{
"date": "20260828",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "RPRX",
"days": [
{
"date": "2026-09-03",
"close": 63.88,
"vwap": 63.48,
"volume": 2761485,
"vwap_discount_pct": -0.63
},
{
"date": "2026-09-02",
"close": 63.11,
"vwap": 62.73,
"volume": 3143774,
"vwap_discount_pct": -0.6
},
{
"date": "2026-09-01",
"close": 62.32,
"vwap": 62.14,
"volume": 2629306,
"vwap_discount_pct": -0.29
},
{
"date": "2026-08-31",
"close": 61.41,
"vwap": 61.36,
"volume": 3895209,
"vwap_discount_pct": -0.09
},
{
"date": "2026-08-28",
"close": 60.85,
"vwap": 60.89,
"volume": 1701654,
"vwap_discount_pct": 0.07
}
],
"avg_vwap_discount_pct": -0.31,
"signal": "Distribution"
},
"options_flow": [],
"net_premium": {
"ticker": "RPRX",
"net_call_premium": "7046.00",
"net_put_premium": "1630.00",
"call_premium": "38030.00",
"put_premium": "4608.00",
"bullish_premium": "22467.00",
"bearish_premium": "17051.00",
"put_call_ratio": "0.15254237288135593220",
"iv_rank": "34.4678",
"implied_move_perc": "0.046000",
"gex_ratio": "0.14381759007250238197",
"gex_net_change": "410.2504",
"gex_call": "33722.5838",
"gex_put": "-4494.9163",
"gex_net": 29227.6675,
"gex_call_delta": "671958.6089",
"gex_put_delta": "-16358.3345",
"gex_date": "2026-09-04"
},
"hot_chains": [
{
"open_interest": 0,
"volume": 145,
"last_price": "2.05",
"option_symbol": "RPRX261218C00067500",
"bid_volume": 52,
"ask_volume": 93,
"avg_price": "2.0155172413793103448275862069",
"nbbo_ask": "2.75",
"nbbo_bid": "1.40"
},
{
"open_interest": 1,
"volume": 10,
"last_price": "1.10",
"option_symbol": "RPRX261016P00060000",
"bid_volume": 0,
"ask_volume": 10,
"avg_price": "1.10",
"nbbo_ask": "1.55",
"nbbo_bid": "0.20"
},
{
"open_interest": 4,
"volume": 8,
"last_price": "0.24",
"option_symbol": "RPRX260918C00070000",
"bid_volume": 8,
"ask_volume": 0,
"avg_price": "0.24",
"nbbo_ask": "2.30",
"nbbo_bid": "0"
},
{
"open_interest": 646,
"volume": 6,
"last_price": "0.67",
"option_symbol": "RPRX260918P00060000",
"bid_volume": 5,
"ask_volume": 1,
"avg_price": "0.5283333333333333333333333333",
"nbbo_ask": "0.75",
"nbbo_bid": "0.30"
},
{
"open_interest": 132,
"volume": 5,
"last_price": "1.90",
"option_symbol": "RPRX260918C00062500",
"bid_volume": 1,
"ask_volume": 4,
"avg_price": "1.80200000",
"nbbo_ask": "2.50",
"nbbo_bid": "1.40"
},
{
"open_interest": 6,
"volume": 5,
"last_price": "2.43",
"option_symbol": "RPRX261016P00042500",
"bid_volume": 4,
"ask_volume": 1,
"avg_price": "2.8840000000000000000000000000",
"nbbo_ask": "4.90",
"nbbo_bid": "0"
},
{
"open_interest": 12,
"volume": 5,
"last_price": "2.51",
"option_symbol": "RPRX261016P00045000",
"bid_volume": 0,
"ask_volume": 5,
"avg_price": "2.9640000000000000000000000000",
"nbbo_ask": "4.90",
"nbbo_bid": "0.10"
},
{
"open_interest": 203,
"volume": 4,
"last_price": "4.80",
"option_symbol": "RPRX261016C00060000",
"bid_volume": 3,
"ask_volume": 1,
"avg_price": "4.2375000000000000000000000000",
"nbbo_ask": "7.40",
"nbbo_bid": "4.00"
}
],
"gamma_profile": {
"ticker": "RPRX",
"spot": 63.7,
"date": "2026-09-04",
"flip_point": 42.65,
"net_gex": 29227.67,
"call_walls": [
{
"strike": 65.0,
"gex": 16036.3
},
{
"strike": 62.5,
"gex": 7136.55
},
{
"strike": 60.0,
"gex": 2910.24
}
],
"put_walls": [
{
"strike": 60.0,
"gex": -3986.87
},
{
"strike": 32.5,
"gex": -146.79
},
{
"strike": 47.5,
"gex": -82.34
}
],
"by_strike": [
{
"strike": 32.5,
"call_gex": 0.0,
"put_gex": -146.79,
"net_gex": -146.79
},
{
"strike": 35.0,
"call_gex": 3.86,
"put_gex": -5.68,
"net_gex": -1.83
},
{
"strike": 37.5,
"call_gex": 0.72,
"put_gex": -13.22,
"net_gex": -12.5
},
{
"strike": 40.0,
"call_gex": 6.15,
"put_gex": -0.54,
"net_gex": 5.61
},
{
"strike": 42.5,
"call_gex": 56.06,
"put_gex": -4.65,
"net_gex": 51.42
},
{
"strike": 45.0,
"call_gex": 1737.02,
"put_gex": -15.94,
"net_gex": 1721.08
},
{
"strike": 47.5,
"call_gex": 1695.31,
"put_gex": -82.34,
"net_gex": 1612.96
},
{
"strike": 50.0,
"call_gex": 755.34,
"put_gex": -20.25,
"net_gex": 735.1
},
{
"strike": 52.5,
"call_gex": 145.61,
"put_gex": -36.47,
"net_gex": 109.13
},
{
"strike": 55.0,
"call_gex": 1424.83,
"put_gex": -64.64,
"net_gex": 1360.19
},
{
"strike": 57.5,
"call_gex": 644.81,
"put_gex": -68.69,
"net_gex": 576.12
},
{
"strike": 60.0,
"call_gex": 2910.24,
"put_gex": -3986.87,
"net_gex": -1076.63
},
{
"strike": 62.5,
"call_gex": 7136.55,
"put_gex": -39.78,
"net_gex": 7096.77
},
{
"strike": 65.0,
"call_gex": 16036.3,
"put_gex": -9.03,
"net_gex": 16027.27
},
{
"strike": 67.5,
"call_gex": 773.8,
"put_gex": 0.0,
"net_gex": 773.8
},
{
"strike": 70.0,
"call_gex": 136.44,
"put_gex": 0.0,
"net_gex": 136.44
},
{
"strike": 75.0,
"call_gex": 222.51,
"put_gex": 0.0,
"net_gex": 222.51
},
{
"strike": 80.0,
"call_gex": 32.46,
"put_gex": 0.0,
"net_gex": 32.46
},
{
"strike": 85.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 90.0,
"call_gex": 4.55,
"put_gex": 0.0,
"net_gex": 4.55
}
]
},
"oi_changes": {
"net_call_oi_change": 0,
"net_put_oi_change": 1,
"top": [
{
"strike": null,
"oi_change": -2,
"type": "call"
},
{
"strike": null,
"oi_change": 2,
"type": "call"
},
{
"strike": null,
"oi_change": 1,
"type": "put"
},
{
"strike": null,
"oi_change": -1,
"type": "call"
},
{
"strike": null,
"oi_change": 1,
"type": "call"
}
]
},
"opds": {
"opds": -10.0,
"D": -37.5,
"P": 57.8,
"O": -17.2,
"C": 26.7,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": 59.7,
"T": 80.5,
"RS": 52.3,
"V": 31.7,
"F": 13.7,
"OI": -100.0,
"S": null,
"IV": -8.8,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": null,
"FlowAgreement": 66.7,
"StrikeBreadth": null
},
"drivers": [
"- open-interest change -100",
"+ trend +81",
"+ momentum +60",
"+ relative strength +52",
"+ price/volume +32"
]
}
}
Data:
{
"vix": 14.92,
"sp500": 7631.47,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.4,
"hy_spread": 2.63,
"treasury": {
"date": "2026-09-02",
"month1": 3.83,
"month2": 3.89,
"month3": 3.92,
"month6": 4,
"year1": 4.16,
"year2": 4.39,
"year3": 4.45,
"year5": 4.54,
"year7": 4.66,
"year10": 4.79,
"year20": 5.27,
"year30": 5.27
},
"events": [
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.1%",
"actual": null,
"minutes_until": -51
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "55K",
"previous": "-23K",
"actual": null,
"minutes_until": -51
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": -51
}
]
}
Data:
{
"days": 105,
"patterns": [
{
"name": "VWAP Touch",
"count": 105,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 100,
"pct": 95
},
{
"name": "Woodie Pivot Touch",
"count": 98,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 93,
"pct": 89
},
{
"name": "Gap Fill",
"count": 74,
"pct": 70
},
{
"name": "Open Retracement",
"count": 70,
"pct": 67
},
{
"name": "High Vol Open",
"count": 27,
"pct": 26
},
{
"name": "Darvas Box",
"count": 24,
"pct": 23
},
{
"name": "Power Hour",
"count": 14,
"pct": 13
}
]
}